Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5576668 | The American Journal of Medicine | 2017 | 9 Pages |
Abstract
Abrupt discontinuation of proton pump therapy can lead to adverse outcomes in patients with Zollinger-Ellison syndrome. Clinical assessment for features of multiple endocrine neoplasia type 1 (eg, serum calcium levels, personal and family history of hypercalcemia, pituitary or pancreatic tumors) could identify patients with higher risk for a tumoral source of hypergastrinemia where imaging studies can help support the diagnosis without the potential side effects of abrupt discontinuation of proton pump inhibitor therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Naykky MD, MS, Diane MB, BCh, BAO, Rene MD, MS, Zahraa MD, William F. MD, MS,